Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

American Heart Month aims to spread awareness of women and heart disease

More than five times as many women are diagnosed with heart disease each year than with breast cancer. American Heart Month in February aims to spread awareness of women and heart disease, and one Alabama company has found the quickest way to a woman's heart might be through her gynecologist.

5 Feb 2010

Online programs may help Americans incorporate more fruits and vegetables in their diet

Online programs that provide information and tips about fruits and vegetables may be the key to getting more Americans to eat healthier, say researchers at Henry Ford Hospital.

5 Feb 2010

Texas Health Dallas offers heart and vascular screening program for women

When Mary Gill went to bed that night, nothing would have made anyone think heart disease — not even Mary. She was thin and 42 years old. She exercised regularly, ate a healthy diet and never smoked.

4 Feb 2010

CardioNet's MCOT service: 300,000th patient benefits

CardioNet, Inc. announced today that the 300,000th patient has been monitored with the Company’s Mobile Cardiac Outpatient Telemetry (MCOT™) service. MCOT is the first system to provide real-time wireless ECG monitoring and 24/7/365 analysis and response.

4 Feb 2010

Micrus Endovascular reports financial results for three and nine months ended December 31, 2009

Micrus Endovascular Corporation today reported financial results for the three and nine months ended December 31, 2009 and raised fiscal 2010 revenue guidance.

4 Feb 2010

Immigrants may be healthier than long-term residents

New immigrants to North America may be less likely to have a stroke at a young age than long-time residents, according to a study published in the February 3, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.

4 Feb 2010

Low Vision of Michigan introduces new device for RP patients

To commemorate Low Vision Awareness Month this February, Dr. Sheldon Smith, optometrist at Low Vision of Michigan, P.C., is offering free evaluations to patients diagnosed with retinitis pigmentosa (RP), a leading cause of low vision, in hopes that they might be candidates for a brand-new device designed to enhance or restore sight.

4 Feb 2010

Type 1 diabetes: Regeneration exhibits potential as a possible cure

A hormone responsible for the body's stress response is also linked to the growth of insulin-producing cells in the pancreas, according to JDRF- funded researchers at the Salk Institute for Biological Studies in California. The findings are the latest advances to underscore the potential for regeneration as a key component of a possible cure for type 1 diabetes.

4 Feb 2010

PLX cell therapy may be an effective treatment for ischemic stroke disorder

Pluristem Therapeutics Inc. today announced that the results of a pre-clinical study in an animal model of ischemic stroke demonstrated that its PLacental eXpanded (PLX) cell therapy may be an effective treatment for this disorder.

4 Feb 2010

Shire's clinical study results for treatment of Gaucher disease to be presented at LDN World Symposium

Shire plc, the global specialty biopharmaceutical company, today announced that data from one of three Phase III clinical trials for velaglucerase alfa, the company's enzyme replacement therapy (ERT) in development for the treatment of Type 1 Gaucher disease, will be presented at the Lysosomal Disease Network (LDN) World Symposium, February 10-12, 2010 in Miami, Florida.

4 Feb 2010

Transplantation of pulmonary progenitor cells derived from hESCs promising for acute lung injury

Stem cell researchers exploring a new approach for the care of respiratory diseases report that an experimental treatment involving transplantable lung cells was associated with improved outcomes in tests on mice with acute lung injury. The lung cells were derived from human embryonic stem cells (hESCs). Findings by investigators at The University of Texas Health Science Center at Houston are scheduled to appear in the March issue of Molecular Therapy.

4 Feb 2010

Organizations across Canada unite as partners to prevent chronic diseases among Canadians

More than 30 organizations from across Canada are uniting as partners in a series of initiatives designed to improve the health of Canadians by preventing chronic disease. A total of $15.5 million is being invested in seven collaborative coalitions addressing such issues as childhood obesity, screening for chronic disease by family doctors, and the unique needs of First Nations communities.

4 Feb 2010

Tough economy adds stress to hospitals; Community health centers help fill gaps

Hospitals get mixed marks while many suffer from the effects of the struggling economy. Meanwhile, community health centers increasingly provide more care and help fill in health care gaps.

4 Feb 2010

Major study of perfusion imaging under way to assess value of alternative diagnostic methods

Cardiologists and heart imaging specialists at 15 medical centers in eight countries, and led by researchers at Johns Hopkins, have enrolled the first dozen patients in a year-long investigation to learn whether the subtle squeezing of blood flow through the inner layers of the heart is better than traditional SPECT nuclear imaging tests and other diagnostic radiology procedures for accurately tracking the earliest signs of coronary artery clogs.

3 Feb 2010

Daiichi Sankyo initiates Phase III trial of edoxaban in reducing recurrent VTE complications

Daiichi Sankyo Company, Limited, announced today that it has initiated a new large-scale pivotal Phase III trial for edoxaban, its investigational oral Factor Xa inhibitor. This new study, called HOKUSAI (pronounced hoe·koo·sigh) VTE, is evaluating the safety and efficacy of edoxaban in reducing recurrent venous thromboembolic (VTE) complications in patients with deep vein thrombosis (DVT) and/or pulmonary embolism (PE).

3 Feb 2010

Go Red For Women launches nationwide call inviting women to Speak Up about heart disease

Too many women die each year because they are unaware that heart disease is their No. 1 killer. Right now, one in three women die of cardiovascular disease and 90 percent of women have one or more risk factors for developing heart disease in the future.

3 Feb 2010

Three year partnership between Dona Bertarelli's Ladycat and Go Red for Women ends

The three year partnership between Dona Bertarelli, her Decision 35 catamaran Ladycat (SUI10) and Go Red for Women, the international campaign of the World Heart Federation to raise public awareness of heart disease and stroke in women, ended successfully in December 2009.

3 Feb 2010

AtriCure announces definitive agreement with DOJ regarding surgical ablation devices

AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems, today announced that it has executed a definitive agreement with the Department of Justice (DOJ) and the Office of Inspector General of the Department of Health and Human Services to resolve the issues raised in the DOJ’s investigation and the related qui tam complaint regarding the marketing of the Company’s surgical ablation devices.

3 Feb 2010

Tips for heart-healthy diet

Lurking in your kitchen may be a killer. According to Saint Louis University cardiologist Melda Dolan, M.D., the fast, convenient and processed foods that fill American's freezers and pantries are bad news for your heart and waistline, as well as your taste buds.

3 Feb 2010

Entelos awarded U.S. patent for apparatus and methods of assessing metabolic substrate utilization

Entelos, Inc., a simulation and modeling company focused on human health, announced today that the U.S. Patent and Trademark Office has granted U.S. Patent No. 7,654,955 entitled “Apparatus and Methods for Assessing Metabolic Substrate Utilization” to the Company. These methods further strengthen the Entelos® Metabolism PhysioLab® platform and leverage insights about human physiology that can lead to improved diagnosis, clinical testing, and personalized treatment across a highly variable patient population.

2 Feb 2010

Stroke News and Research

Further Reading

American Heart Month aims to spread awareness of women and heart disease

Online programs may help Americans incorporate more fruits and vegetables in their diet

Texas Health Dallas offers heart and vascular screening program for women

CardioNet's MCOT service: 300,000th patient benefits

Micrus Endovascular reports financial results for three and nine months ended December 31, 2009

Immigrants may be healthier than long-term residents

Low Vision of Michigan introduces new device for RP patients

Type 1 diabetes: Regeneration exhibits potential as a possible cure

PLX cell therapy may be an effective treatment for ischemic stroke disorder

Shire's clinical study results for treatment of Gaucher disease to be presented at LDN World Symposium

Transplantation of pulmonary progenitor cells derived from hESCs promising for acute lung injury

Organizations across Canada unite as partners to prevent chronic diseases among Canadians

Tough economy adds stress to hospitals; Community health centers help fill gaps

Major study of perfusion imaging under way to assess value of alternative diagnostic methods

Daiichi Sankyo initiates Phase III trial of edoxaban in reducing recurrent VTE complications

Go Red For Women launches nationwide call inviting women to Speak Up about heart disease

Three year partnership between Dona Bertarelli's Ladycat and Go Red for Women ends

AtriCure announces definitive agreement with DOJ regarding surgical ablation devices

Tips for heart-healthy diet

Entelos awarded U.S. patent for apparatus and methods of assessing metabolic substrate utilization

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News